116 related articles for article (PubMed ID: 23341480)
1. Reply to 'Different outcome variables yield different results', by O. Brouckaert et al.
Truin W; Voogd AC; Roumen RMH
Ann Oncol; 2013 Feb; 24(2):555. PubMed ID: 23341480
[No Abstract] [Full Text] [Related]
2. Different outcome variables yield different results!
Brouckaert O; Wildiers H; Neven P
Ann Oncol; 2013 Feb; 24(2):554. PubMed ID: 23277485
[No Abstract] [Full Text] [Related]
3. Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer.
Truin W; Voogd AC; Vreugdenhil G; van der Heiden-van der Loo M; Siesling S; Roumen RM
Ann Oncol; 2012 Nov; 23(11):2859-2865. PubMed ID: 22745216
[TBL] [Abstract][Full Text] [Related]
4. Different adjuvant chemotherapy regimens in older breast cancer patients?
Wildiers H; Brain E
Ann Oncol; 2015 Apr; 26(4):613-615. PubMed ID: 25600566
[No Abstract] [Full Text] [Related]
5. Upfront adjuvant aromatase inhibitors in women with lobular breast cancer.
Montemurro F
Eur J Cancer; 2013 Oct; 49(15):3376-7. PubMed ID: 23867125
[No Abstract] [Full Text] [Related]
6. Inhibiting angiogenesis in breast cancer: the beginning of the end or the end of the beginning?
Rugo HS
J Clin Oncol; 2012 Mar; 30(9):898-901. PubMed ID: 22331930
[No Abstract] [Full Text] [Related]
7. Letter to the editor - author's response.
van de Water W; Fontein DB; van de Velde CJ
Eur J Cancer; 2013 Oct; 49(15):3378-9. PubMed ID: 23890770
[No Abstract] [Full Text] [Related]
8. De-escalation attempts for adjuvant trastuzumab: longer beats shorter.
Curigliano G; Goldhirsch A
Ann Oncol; 2015 Jul; 26(7):1275-6. PubMed ID: 26002609
[No Abstract] [Full Text] [Related]
9. Management of Premenopausal Women with Neoadjuvant Endocrine Therapy: A Single-Institution Experience.
Barbie TU; Ma C; Margenthaler JA
Ann Surg Oncol; 2015 Nov; 22(12):3861-5. PubMed ID: 25783678
[TBL] [Abstract][Full Text] [Related]
10. [A case of combined noninvasive ductal and lobular carcinoma].
Nagashima S; Sakurai K; Suzuki S; Hara Y; Waga E; Iizuka M; Fuchinoue T; Hirano T; Enomoto K; Tani M; Masuda S; Amano S; Koshinaga T
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2033-5. PubMed ID: 23267967
[TBL] [Abstract][Full Text] [Related]
11. Infiltrating lobular carcinoma of the breast: systemic treatment.
Farese SA; Aebi S
Breast Dis; 2008-2009; 30():45-52. PubMed ID: 19850995
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response?
Chen JH; Mehta RS; Nalcioglu O; Su MY
Ann Surg Oncol; 2008 Dec; 15(12):3609-13. PubMed ID: 18807091
[No Abstract] [Full Text] [Related]
13. Hormone receptor-positive invasive lobular and ductal carcinoma of the breast have comparable hormone receptor expression levels both if detected by screening and clinically.
Ravaioli A; Falcini F; Bucchi L
Breast Cancer Res Treat; 2018 Feb; 167(3):817-818. PubMed ID: 29027616
[No Abstract] [Full Text] [Related]
14. [Response evaluation with mammography and ultrasound].
Junkermann H; Schmid H; Sinn HP; Wallwiener D
Zentralbl Gynakol; 1996; 118(10):572-3. PubMed ID: 8999712
[No Abstract] [Full Text] [Related]
15. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
[TBL] [Abstract][Full Text] [Related]
16. Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis.
van de Water W; Fontein DB; van Nes JG; Bartlett JM; Hille ET; Putter H; Robson T; Liefers GJ; Roumen RM; Seynaeve C; Dirix LY; Paridaens R; Kranenbarg EM; Nortier JW; van de Velde CJ
Eur J Cancer; 2013 Jan; 49(2):297-304. PubMed ID: 22954666
[TBL] [Abstract][Full Text] [Related]
17. A woman with breast cancer and severe impaired lactose tolerance: an intriguing therapeutic dilemma.
Zagouri F; Dimitrakakis C; Dimopoulos MA; Tsigginou A; Antsaklis A; Papadimitriou CA
Breast J; 2012; 18(6):628-9. PubMed ID: 23009609
[No Abstract] [Full Text] [Related]
18. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
[TBL] [Abstract][Full Text] [Related]
19. t(8;16) AML developed subsequent to breast cancer therapy.
Sahin FI; Yilmaz Z; Karakuş S; Boğa S; Akçali Z; DemIrhan B
Hematology; 2006 Jun; 11(3):153-5. PubMed ID: 17326321
[TBL] [Abstract][Full Text] [Related]
20. Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.
Erkanli S; Kayaselcuk F; Kuscu E; Bolat F; Sakalli H; Haberal A
Breast; 2006 Aug; 15(4):558-61. PubMed ID: 16311034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
